Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain PLSE message board posts where the ticker symbol PLSE has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest PLSE SEC Filings

Filings Format Description Filed/Effective File/Film Number
8-K12B  Documents Notification that a class of securities of successor issuer is deemed to be registered pursuant to section 12(b), items 1.01, 3.03, 5.03, 8.01, and 9.01
Acc-no: 0001625101-18-000036 (34 Act)  Size: 963 KB
2018-06-18 001-37744
18905215
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-035292 Size: 5 KB
2018-06-04
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-033158 Size: 5 KB
2018-05-24
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-033155 Size: 5 KB
2018-05-24
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-033152 Size: 5 KB
2018-05-24
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-033150 Size: 5 KB
2018-05-24
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-033146 Size: 5 KB
2018-05-24
8-K  Documents Current report, item 5.07
Acc-no: 0001625101-18-000032 (34 Act)  Size: 66 KB
2018-05-23 001-37744
18855883
424B3  Documents Prospectus [Rule 424(b)(3)]
Acc-no: 0001625101-18-000030 (33 Act)  Size: 159 KB
2018-05-22 333-224800
18852633
EFFECT  Documents Notice of Effectiveness
Acc-no: 9999999995-18-001297 (33 Act)  Size: 1 KB
2018-05-21 16:00:00 333-224800
18851227
More PLSE SEC Filings


Related news from
Thu, 12 Jul 2018
18:30:00 +0000
Pulse Biosciences to Report Second Quarter 2018 Financial Results and Operational Highlights
Pulse Biosciences, Inc. , a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation platform, today announced that the Company will report second quarter 2018 operational highlights and financial results on Tuesday, July 31, 2018.
Tue, 10 Jul 2018
20:00:00 +0000
Pulse Biosciences Announces Treatment of First Patients in Study to Evaluate the Safety and Efficacy of Novel Nano-Pulse Stimulation for the Treatment of Sebaceous Hyperplasia Lesions
Pulse Biosciences, Inc. (PLSE) today announced treatment of the first patients in its multicenter study to evaluate the safety and efficacy of its Nano-Pulse Stimulation (NPS) technology for eliminating Sebaceous Hyperplasia (SH), an unsightly benign skin lesion that typically appears on facial skin and is considered a difficult-to-treat condition with current modalities. NPS is a non-thermal technology that utilizes ultra-short, nanosecond pulsed electrical fields to directly affect cell membranes and intracellular structures while sparing non-cellular tissues.
Tue, 26 Jun 2018
00:07:00 +0000
Robbins Arroyo LLP Is Investigating the Officers and Directors of Pulse Biosciences, Inc. (PLSE) on Behalf of Shareholders
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Pulse Biosciences, Inc. breached their fiduciary duties to shareholders.
Mon, 25 Jun 2018
12:00:00 +0000
Pulse Biosciences Grants Equity Incentive Awards to New Employees
Pulse Biosciences, Inc. (PLSE), a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation (NPS) platform, announced today that the Compensation Committee of the company’s Board of Directors granted non-qualified stock options covering an aggregate of 30,000 shares of Pulse Biosciences common stock to two new non-executive employees under the Pulse Biosciences 2017 Inducement Equity Incentive Plan on June 22, 2018. The 2017 Inducement Equity Incentive Plan is used exclusively to grant equity awards to individuals who were not previously an employee or non-employee director of Pulse Biosciences as an inducement material to such individual's entering into employment with Pulse Biosciences in accordance with Nasdaq Marketplace Rule 5635(c)(4).
Wed, 20 Jun 2018
12:00:00 +0000
Kaskela Law LLC Announces Investigation of Pulse Biosciences, Inc. on Behalf of Stockholders
RADNOR, PA / ACCESSWIRE / June 20, 2018 / Kaskela Law LLC is investigating Pulse Biosciences, Inc. ("Pulse" or the "Company") (NASDAQ: PLSE) on behalf of the Company's stockholders. ...
Tue, 08 May 2018
20:28:00 +0000
Pulse Biosciences Quarterly Investor Conference Call
Pulse Biosciences, Inc. , a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation platform, today reported recent corporate developments and financial results for the first quarter ended March 31, 2018.
Mon, 30 Apr 2018
20:01:00 +0000
Pulse Biosciences to Report First Quarter 2018 Financial Results and Operational Highlights
Pulse Biosciences, Inc. , a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation platform, today announced that the Company will report first quarter 2018 financial results and operational highlights on Tuesday, May 8, 2018.
Wed, 18 Apr 2018
20:00:00 +0000
Pulse Biosciences Grants Equity Incentive Awards to New Employee
Pulse Biosciences, Inc. , a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation platform, today announced that the Compensation Committee of the company’s Board of Directors granted non-qualified stock options covering an aggregate of 300,000 shares of Pulse Biosciences common stock to one new employee under the Pulse Biosciences 2017 ...
Fri, 13 Apr 2018
20:32:00 +0000
Why Alaska Air Group, Pulse Biosciences, and BJ's Restaurants Jumped Today
Learn which companies rose on better business conditions in their industry.
Fri, 13 Apr 2018
12:30:09 +0000
Benzinga Pro's 5 Stocks To Watch Today
Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! Financial Select Sector SPDR Fund (NYSE: XLF ) stock ...
Thu, 12 Apr 2018
21:19:00 +0000
Pulse Biosciences Announces Positive Results from Its First Study Evaluating a Clinical Target at Major Scientific Meeting
Pulse Biosciences, Inc. announced clinical efficacy results of its first multi-center study of Nano-Pulse Stimulation technology for the treatment of seborrheic keratosis lesions in humans.
Fri, 16 Mar 2018
13:30:00 +0000
Pulse Biosciences, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / March 16, 2018 / Pulse Biosciences, Inc. (NASDAQ: PLSE ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 16, 2018, at 4:30 PM Eastern ...
Fri, 16 Mar 2018
10:54:35 +0000
Is Pulse Biosciences Inc’s (NASDAQ:PLSE) CEO Incentives Align With Yours?
Darrin Uecker is the CEO of Pulse Biosciences Inc (NASDAQ:PLSE), which has recently grown to a market capitalization of US$266.53M. Recognizing whether CEO incentives are aligned with shareholders is aRead More...
Thu, 08 Mar 2018
18:45:00 +0000
Pulse Biosciences to Report Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights
Pulse Biosciences, Inc. , a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation platform, today announced that the Company will report fourth quarter and full year 2017 financial results and operational highlights on Friday, March 16th, 2018.
Tue, 19 Dec 2017
12:10:00 +0000
Blog Exposure - Pulse Biosciences Grants Equity Inducement Awards to Its New Employees
Stock Monitor: Lakeland Industries Post Earnings Reporting LONDON, UK / ACCESSWIRE / December 19, 2017 / Active-Investors issued a free report on Pulse Biosciences, Inc. (NASDAQ: PLSE ), which is readily ...



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "VF is a great group of value seeking investors, who are most generous in sharing their research, news, business expertise, and investment experience. It is an invaluable resource, and brings many 'lessons learned' to the group." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards